Person

Edward Morrow Atkinson III

EVP, Chief Technical Ops. Off., Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$11.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 25, 2026VRTXSale668$486.35$325K
Feb 18, 2026VRTXSale817$473.68$387K
Feb 17, 2026VRTXSale2,031$489.46$994K
Feb 11, 2026VRTXSale1,751$460.43$806K
Nov 17, 2025VRTXSale2,500$434.58$1.1M
Feb 27, 2025VRTXSale2,650$475.34$1.3M
Feb 25, 2025VRTXSale1,767$480.95$850K
Feb 11, 2025VRTXSale1,747$459.83$803K
Jun 12, 2024VRTXSale7,288$478.00$3.5M
Feb 26, 2024VRTXSale883$425.70$376K
Feb 21, 2024VRTXSale1,201$421.77$507K
Feb 20, 2024VRTXSale801$420.79$337K
Feb 12, 2024VRTXSale913$420.24$384K

SEC reporting-owner ID (CIK) 1914164 · all filings on EDGAR

Edward Morrow Atkinson III (VRTX) | USBoard